Silica: No UL, Low Risk at 10-40 mg/day (EFSA)

Silicon (sold as silica or orthosilicic acid) is marketed for hair, skin, and nails, but authoritative ULs are less standardized than for classic vitamins. Conservative dosing and product quality matter. Contaminant risk is a manufacturing issue: choose brands with transparent testing. Silica and orthosilicic acid marketing targets hair, skin, and nails, yet multiple beauty stacks plus mineral complexes can aggregate silicon-containing ingredients without clear benefit thresholds. Renal considerations matter when users concentrate many mineral powders daily. Treat each bottle as a line item with dose, frequency, and ingredient form—not only a brand name. NutriAudit normalizes units, flags duplicate nutrient paths across products, and surfaces totals that approach tolerable upper intake levels from authoritative references. Use the export as a conversation starter with your clinician before surgery, pregnancy, new prescriptions, or whenever symptoms shift alongside product changes. Retail marketing and percent daily value lines do not replace summing the same vitamin or mineral across every source you actually take in a day. Proprietary blends still leave you responsible for recognizable vitamins and minerals underneath; photograph both the marketing panel and the Supplement Facts table when you open a new bottle so later dose reconstruction does not depend on memory alone. Bleeding risk is one of the most common supplement–drug interaction themes because patients combine fish oil, high-dose vitamin E, turmeric/curcumin, garlic concentrates, ginkgo, and NSAIDs without summing antiplatelet burden. Sedation stacks layer melatonin, valerian, antihistamines, alcohol, and prescription sleep aids until morning impairment and fall risk rise, especially in older adults. Serotonergic stacking can occur when St John’s wort or high-dose tryptophan-adjacent products overlap SSRIs, SNRIs, MAOIs, or triptans. These are not “maybe someday” interactions; they are emergency-department patterns when disclosure fails. Your written stack list should include doses, brands, and start dates so clinicians can interpret symptoms temporally. Label percent daily value is a teaching tool aligned to population reference intakes, not a toxicity meter. You can be below 100% DV on every bottle yet exceed a UL when four bottles each carry 50–80% of the same nutrient. Conversely, B12 labels showing thousands of percent DV reflect absorption science, not a mandate to stack five B12 products. “Natural,” “clean,” and “pharmaceutical grade” are marketing phrases without standardized regulatory definitions for safety. Third-party testing certifications help quality-minded buyers but do not replace arithmetic on totals. If marketing claims cite a single study, ask whether that study used the same population, dose, and duration as your stack. Long-term supplement habits deserve periodic review the same way medications do: indications change, kidney function changes, diets change, and goals change. A seasonal vitamin D strategy at higher latitude differs from year-round megadosing without 25(OH)D monitoring. Iron repletion should have an endpoint informed by ferritin and symptoms, not infinite pills because fatigue persisted for unrelated reasons. Protein powders displace whole-food meals for some busy users, creating micronutrient gaps that another capsule cannot honestly fix. If a supplement has not produced a measurable or symptomatic benefit after a reasonable trial window, reconsider the diagnosis and the product rather than adding compensatory layers. Fat-soluble vitamins accumulate in tissue stores, so chronic modest excess can matter even when each individual dose “looks fine” relative to a marketing claim. Water-soluble vitamins are cleared faster, yet several still have real ULs, vitamin C, vitamin B6, and niacin are common examples, or predictable dose-dependent side effects at chronic high intake. Minerals such as iron, zinc, copper, selenium, and iodine participate in narrow therapeutic windows where deficiency and toxicity are both clinically relevant. Electrolytes like potassium become dangerous quickly when kidney function declines or when RAAS-inhibiting medications are present. Herbal and adaptogen categories add pharmacologic variability even when labels say “natural.” Thinking in categories, fat-soluble, UL minerals, sedating herbals, enzyme-inducing herbals, helps prioritize what to audit first. Kidney disease shifts the safety curve for magnesium, potassium, vitamin D metabolites, and some protein-adjacent supplement categories. Liver disease changes retinoid storage, clotting factor production, and detoxification capacity for concentrated herbal extracts. Malabsorption syndromes, bariatric anatomy, celiac disease, and inflammatory bowel flares change which forms and doses are appropriate even when a generic blog recommends a “standard” amount. Athletes may have higher turnover for some nutrients yet still face iron misadventure if they stack multiple iron paths without ferritin monitoring. None of these contexts are solved by buying a more expensive brand; they require individualized medical planning with periodic labs when indicated. NutriAudit encourages you to export a single stack summary for clinicians whenever totals approach reference limits or when new symptoms coincide with product changes. Revisit the audit after hospital discharge, a course of antibiotics, intentional weight loss, or any sustained diet pattern shift that changes what you eat every day.